1 year return (CAGR)
32.23%
Alx Oncology Holdings Exchange (NASDAQ, USD)
ALXO
1.60
-0.06 (-3.61%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-32.40%
5 year return (CAGR)
-54.04%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
221.24M
Price/Sales
-
Ent value
223.19M
Price/Book
1.62
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-5.19%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.68 |
| Daily high | 1.68 |
| Daily low | 1.60 |
| Daily Volume | 653K |
| All-time high | 112.26 |
| 1y analyst estimate | 4.60 |
| Beta | 0.40 |
| EPS (TTM) | -0.60 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ALXO | S&P500 | |
| Current price drop from All-time high | -98.57% | -0.58% |
| Highest price drop | -99.64% | -56.47% |
| Date of highest drop | 27 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -80.02% | -10.68% |
| Avg time to new high | 74 days | 12 days |
| Max time to new high | 1451 days | 1805 days |
News
